Afya (AFYA) LT-Debt-to-Total-Asset : 0.32 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Afya LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Afya's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.32.

Afya's long-term debt to total assets ratio declined from Mar. 2023 (0.33) to Mar. 2024 (0.32). It may suggest that Afya is progressively becoming less dependent on debt to grow their business.

Afya LT-Debt-to-Total-Asset Historical Data

The historical data trend for Afya's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afya LT-Debt-to-Total-Asset Chart

Afya Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.20

0.31

0.34

0.32

Afya Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.33	0.33	0.33	0.32	0.32

Afya LT-Debt-to-Total-Asset Calculation

Afya's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	501.897	/	1547.916
	=	0.32

Afya's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	498.801	/	1544.404
	=	0.32

Afya (NAS:AFYA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Afya LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Afya's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Afya (AFYA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » Afya Ltd (NAS:AFYA) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

1AY:Germany 1AY:Germany A2FY34:Brazil

Address

Alameda Oscar Niemeyer, No. 119, Room 504, Vila da Serra, Nova Lima, MG, BRA

Website

https://www.afya.com.br

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.